Home Search

epidiolex - search results

If you're not happy with the results, please do another search
Brexit and medicinal cannabis in the UK

Brexit’s Medical Cannabis Sting For UK Paediatric Patients

The UK’s Brexit transition period ends on 1 January 2021, and with it access to medical cannabis prescriptions filled in the EU. From January 1,...
GW Pharmaceuticals - Epidyolex in Australia

Australia’s TGA Approves Cannabidiol (CBD) Medicine

GW Pharmaceuticals announced last week the Australian Therapeutic Goods Administration (TGA) has approved its cannabidiol medicine Epidyolex for the treatment of seizures associated with...
Cannabinoids and prescription medication

Researchers: Cannabinoids May Impact Prescription Drug Effects

Penn State College of Medicine researchers have found products containing cannabinoids may have impacts on the effects of some conventional prescription drugs. The researchers have...
CBD medication approved for tuberous sclerosis complex

CBD Medicine Approved For TSC Treatment In The USA

GW Pharmaceuticals has achieved one of its goals for this year - seeing Epidiolex approved for the treatment of seizures associated with tuberous sclerosis...
GW Pharmaceuticals Epidyolex

Cannabidiol Medicine Downscheduled In The UK

GW Pharmaceuticals' Epidyolex has been rescheduled in the UK, making life easier for patients, healthcare professionals and pharmacists. Epidyolex, which is marketed as Epidiolex in...
Epidiolex descheduled

Cannabidiol-Based Medicine Descheduled In The USA

GW Pharmaceuticals announced yesterday the United States Drug Enforcement Administration (DEA) has determined Epidiolex is no longer subject to the Controlled Substances Act (CSA),...
USA FDA and cannabidiol

U.S. FDA Releases Cannabidiol Update

The U.S. Food and Drug Administration has provided an update to Congress on where it's at on evaluation of cannabidiol (CBD) products. It still...
Cannabidiol dietary supplement marketing ban

New Bill Seeks To Overturn U.S. CBD Dietary Supplement Marketing Ban

Chair of the USA's House Agriculture Committee Collin Peterson has sponsored a bipartisan bill that would enable the FDA to allow marketing of hemp-derived...
GW Pharmaceuticals - Epidiolex

GW Pharmaceuticals Turning Big Bucks From CBD

GW Pharmaceuticals (Nasdaq:GWPH) has posted better than expected results on the back of its cannabidiol-based medication Epidiolex. The company expects its total net product sales...
U.S. FDA and cannabidiol

FDA Publishes Revised Consumer Update On CBD

The U.S. Food and Drug Administration has sent another batch of warning letters to CBD vendors and again expressed concerns about the safety of...
Hemp Seed